/PRNewswire/ Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), one of.
Salix Pharmaceuticals' First Liver Health Annual Trends Report Highlights Urgent Need for Evidence-Based Guidelines to be Adopted by Physicians Bausch Health Companies Inc. and its gastroenterology business, Salix Pharmaceuticals one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal and liver diseases, today released key findings from a .